CORONARY ARTERY DISEASE IN WOMEN by DR ABHISHEK RATHOREdrabhishekbabbu
CAD is the leading cause of death in women. Here is the current scenerio of CAD in women. In what matter CAD in women differs from man is presented hare.
Black American women have higher rates of many risk factors for heart disease, including obesity, physical inactivity, metabolic syndrome, diabetes, and hypertension than white women
What are the cardiovascular disorders?
Public Health importance
Burden of disease
Risk factors of cardiovascular disorders
Causation
Prevention strategies
Global Action Plan for the Prevention and Control of NCDs
India - National programme (NPCDCS)
Incidence and Epidemiology of Cardiovascular Disease: Doug Levy
Presentation by Lee Goldman, MD, at TCT 2011 conference. Goldman is dean of the faculties of health sciences and medicine and executive vice president of Columbia University Medical Center. For more information, go to http://cumc.columbia.edu/newsroom or call 212-305-3900.
Our aim is to reduce morbidity and mortality related to Non communicable diseases such as hypertension, diabetes, cardiovascular disease, stroke, Obesity, Cancer and lifestyle diseases among those least able to withstand the burden of the disease.
Women and Heart Disease: New Concepts in Prevention and ManagementSummit Health
Coronary heart disease is the leading cause of
death for all women. Significant disparities
exist in the prevention, diagnosis, recognition,
management, and clinical outcomes of
cardiovascular disease in women.
CORONARY ARTERY DISEASE IN WOMEN by DR ABHISHEK RATHOREdrabhishekbabbu
CAD is the leading cause of death in women. Here is the current scenerio of CAD in women. In what matter CAD in women differs from man is presented hare.
Black American women have higher rates of many risk factors for heart disease, including obesity, physical inactivity, metabolic syndrome, diabetes, and hypertension than white women
What are the cardiovascular disorders?
Public Health importance
Burden of disease
Risk factors of cardiovascular disorders
Causation
Prevention strategies
Global Action Plan for the Prevention and Control of NCDs
India - National programme (NPCDCS)
Incidence and Epidemiology of Cardiovascular Disease: Doug Levy
Presentation by Lee Goldman, MD, at TCT 2011 conference. Goldman is dean of the faculties of health sciences and medicine and executive vice president of Columbia University Medical Center. For more information, go to http://cumc.columbia.edu/newsroom or call 212-305-3900.
Our aim is to reduce morbidity and mortality related to Non communicable diseases such as hypertension, diabetes, cardiovascular disease, stroke, Obesity, Cancer and lifestyle diseases among those least able to withstand the burden of the disease.
Women and Heart Disease: New Concepts in Prevention and ManagementSummit Health
Coronary heart disease is the leading cause of
death for all women. Significant disparities
exist in the prevention, diagnosis, recognition,
management, and clinical outcomes of
cardiovascular disease in women.
Heart disease describes a variety of conditions that affect the coronary heart. Diseases underneath the coronary heart sickness umbrella consist of blood vessel diseases, together with coronary artery disorder, heart rhythm problems arrhythmias and heart defects, human beings are born with congenital heart defects , among others. If the heart disorder isnt recognized at an early stage, the patient's situation might get worsened and for that reason endanger his life. Therefore, this software program is evolved in order to research the patient check details and give an evaluation as to whether or not the affected person is healthful or requires remedy for heart disorder by giving the intensity of patient's heart situation because the result. Prof. Vikrant Chole | Karishma V. Bagde "Heart Disease Analysis System" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd31070.pdf Paper Url :https://www.ijtsrd.com/engineering/other/31070/heart-disease-analysis-system/prof-vikrant-chole
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
How can the incidence of heart disease among women be lowered?
1. Heart disease among women 1
How can the incidence of
heart disease among women be lowered?
Prepared for:
S Williams
Pathophysiology
SPRA11 Section G
Prepared by:
Mary Strube
April 8, 2011
2. Heart disease among women 2
How can the incidence of heart disease among women be lowered?
The purpose of this paper is to explore the common beliefs of people about heart disease,
investigate the signs, symptoms, risk factors and preventative strategies of heart disease, and
determine how the incidence of heart disease among women can be lowered. This topic is being
considered because heart disease is a serious yet seriously misunderstood disease especially in
the female community of the United States, and thorough examination of this topic is key to
interpreting why it is misunderstood and what can be done to change that.
Heart disease is not just a man’s disease. It is the number one leading cause of death of
men and women both in America and worldwide. According to the World Health Organization
(WHO), there are more people worldwide who have died from coronary heart disease (CHD)
since 1990 than from any other cause. The WHO has said that heart disease is a “…true
pandemic that respects no borders.” (WHO, Deaths from, 2010). The Centers for Disease
Control (CDC) has stated (Brownstein, 2008, page 1) that cardiovascular disease is the foremost
cause of death in the United States. Experts warn us that heart disease is not just a problem for
men as was once supposed. Heart disease is the leading cause of death of women. According to
the WHO (WHO, 2009), though cardiovascular disease is generally considered to be a disease
reserved only for men, it is the number one killer of women across the globe. 45% of deaths in
women over the age of 60 come about because of chronic conditions including cardiovascular
disease. The fact is that not only are many women dying of heart disease, but many women are
living with heart disease as well. Texas Health Resources (Texas Health Resources, 2011) tells
us that one in 3 adult women has some form of heart or vascular disease, and these numbers are
expected to only get worse. The instance of heart disease is escalating in both men and women.
According to an article published in the National Institute of Health (NIH) (Fang, 2008), the
3. Heart disease among women 3
number of admissions to hospitals for heart related illness tripled between 1979 and 2004. Rates
of mortality are improving, but they are not improving across gender lines. The National Heart
Lung and Blood Institute (NHBLI) (NHLBI, 2009) states that though mortality rates from heart
attacks have improved significantly in the past 30 years, the results are not as positive for women
as they are for men.
The symptoms and signs of heart disease are not always the same with women as they are
in men. Because women experience symptoms and signs differently than men do, it is important
to note the similarities and differences if change is to be made. Men generally suffer from the
more widely recognized, tradition signs of heart disease. As stated by the NIH (NHBLI, What
are, N.D.), men report feeling a pressure or squeezing in the chest that may extend to one or both
arms. This pain, called angina, tends to worsen with physical exertion. It also eases with rest or
sleep. Signs of heart disease in women may differ greatly from men. Women do experience
chest pain, but the pain is sharp and may radiate into the neck, jaw, throat or upper back, and
women are more likely to have angina while resting, sleeping or doing routine activities.
Additionally, women are more likely to experience angina as a response to mental stress. A
woman may also experience heartburn or indigestion, nausea, vomiting and fatigue. She might
feel a fluttering in the chest caused by heart palpitations, and experience swelling of the lower
body and extremities. Some women may have no signs or symptoms at all until they have a
heart attack. Although symptoms and signs certainly may vary by individual, women far more
likely than men to present with atypical signs. Sutter Health Cardiologist Zi-Jian Xu, M.D.,
FACC, Ph.D has stated (Sutter Health, 2011) that while women do experience many of the
traditional symptoms and signs of heart disease, they are more likely to experience vague
4. Heart disease among women 4
symptoms such as fatigue or lack of stamina, vague discomfort or pain, or simply a general sense
of discomfort.
Heart disease in women is not always diagnosed as it should be. Women can be under
diagnosed when it comes to heart disease. According to WHO (WHO, 2009), because the
symptoms of cardiovascular disease are not the same in women as they are in men, women are
often under diagnosed. Because symptoms of heart disease are atypical in women, they are more
likely to be diagnosed with a condition other than heart disease. According to
TheHeartDisease.net (HerbalBloom, 2008), because women experience nausea and vomiting as
signs of disease, doctors often diagnose a gastrointestinal problem rather than a cardiac one.
Women are also likely to receive delayed diagnosis when it comes to heart disease. The NIH has
said (NHLBI, What are, N.D.) that the signs of a CHD may differ between men and women.
Some women suffer from silent CHD, which is a condition of having CHD but exhibiting no
signs or symptoms at all. As a result, these women are not diagnosed with heart disease until
they experience a heart attack, heart failure or irregular heartbeat. TheHeartDisease.net goes
further to say (HerbalBloom, 2008) that women wait on average 25 minutes longer than men to
receive treatments to break up clots. This treatment when given in a timely manner can stop a
heart attack. Failure to receive this treatment leads to increased risk of stroke and death.
Though symptoms and signs of heart disease may vary greatly between men and women,
many of the risk factors are the same, with only a few exceptions. Controllable risk factors for
women are largely the same as they are for men. The American Heart Association’s (AHA) Go
Red for Women campaign (AHA, n.d.) lists major risk factors as high cholesterol, high blood
pressure, smoking, physical inactivity, obesity, diabetes, stress, the use of birth control pills, and
alcohol and illegal drug use as major etiologies in the progression of heart disease. The NIH
5. Heart disease among women 5
(NHLBI, What causes, N.D.) adds low estrogen levels and high levels of stress hormones to this
list, and the CDC (CDC, 2011) includes poor diet. Risk factors that a patient has no control over
are also similar between men and women. According to the AHA (AHA, N.D.), family history,
race, increasing age, gender, and previous instance of heart attack or stroke are all risk factors for
the occurrence of heart disease in both men and women. There are, however some significant
differences when it comes to the development of heart disease. One significant difference, as
noted by the NIH (NHLBI, 2009), is that women tend to suffer from heart disease about 10 years
later in life than do men. As a result the mortality rate is higher because of the likelihood that
she will have other serious health problems that likely will impede her recovery.
The incidence of heart disease can be reduced through prevention, but this is a viable
option only if women become aware of it. The WHO has stated (WHO, Prevention, 2010) that
key factors in reducing the risk of heart disease are having good control of blood pressure,
cholesterol and blood glucose, and that personal behavior and lifestyle can make a difference and
help in the reduction of the risk of developing this disease. Prevention is very important because
as the NIH tells us two thirds of women who have a heart attack never fully recover. (NIH, n.d.)
Few women know their risk of developing heart disease. According to a study published in
Harvard Health Publications (Harvard, 2010-2011), about half of women in the United States
knew that heart disease is the number one killer of women, but only 13% felt a personal risk.
The WHO asserts than 2/3 of patients who die within 28 days of first experiencing symptoms of
a heart attack die on the way to the hospital, highlighting the need for awareness and prevention.
Further, many women are not aware of the importance of controlling their risk factors. As the
WHO iterates, although genetics do play a small role in the development of the disease, in cases
of mortality 80%-90% of the people who died had at least one, but often more than one, major
6. Heart disease among women 6
risk factors that were influenced by choices in the patient’s life. (WHO, Deaths, 2010)
Awareness campaigns have proven to be a reliable way to reduce the incidence of heart disease
in at risk population, including women. WHO studies have revealed that the death rate of heart
disease patients is declining, and they attribute this decrease to increased prevention diagnosis
and treatment. Awareness has led to a lower number of smokers, and lower blood pressure and
blood cholesterol levels across the world, contributing to the better figures. (WHO, Deaths,
2010) The CDC has found (Brownstein, 2008, page 2) that counseling programs which teach
healthy habits to at risk populations not only supports healthy lifestyles but also prevents
cardiovascular diseases.
As the preceding research has shown, heart disease is not a disease reserved solely for
men. Heart disease is a condition that spans all people, including women. It has been proven
that heart disease affects 1 of every 3 women not only in the United States, but worldwide.
Studies have shown that although risk factors for the disease affect everyone similarly, the
symptoms and signs of heart disease do vary greatly between men and women. Knowing these
differences, as stated above, can vastly improve the outcome of heart episodes. Research has
proven that heart disease can be prevented through lifestyle change, and that by increasing
awareness of these facts and encouraging prevention of the disease through the control of risk
factors the incidence of heart disease in women can indeed be reduced.
7. Heart disease among women 7
References
AHA GoRed for Women. (N.D.). Understand your risks. Retrieved from:
http://www.goredforwomen.org/understand_your_risks.aspx
Brownstein, J. Nell. (April, 2008). Addressing heart disease and stroke prevention through
comprehensive population-level approaches. Preventing Chronic Disease, Vol. 5 (No. 2).
Retrieved from: http://www.cdc.gov/pcd/issues/2008/apr/pdf/07_0251.pdf
CDC. (February, 2011). Women and heart disease prevention. Retrieved from:
http://www.cdc.gov/women/heart/
Fang J., Mensah G.A., Croft J.B., Keenan N.L. (August, 2008). Heart Failure-Related
Hospitalization in the U.S., 1979 to 2004 [Abstract]. Journal of the American College of
Cardiology, 52 (6), pp. 428-434. Retrieved from:
http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&db=pubmed&cmd=Search
&term=428[page]%20AND%20Fang%20J[author]
Harvard Medical School. (2010-2011). Gender matters: heart disease risk in women. Retrieved
from:
http://www.health.harvard.edu/newsweek/Gender_matters_Heart_disease_risk_in_wome
n.htm
HerbalBloom. (February, 2008). Failure to diagnose heart attacks most common medical
malpractice. Retrieved from: http://www.theheartdisease.net/573/failure-to-diagnose-
heart-attacks-most-common-medical-malpractice/
NHLBI. (N.D.). What are the signs and symptoms of heart disease? Retrieved from:
http://www.nhlbi.nih.gov/health/dci/Diseases/hdw/hdw_signsandsymptoms.html
NHLBI (N.D.). What causes heart disease? Retrieved from:
http://www.nhlbi.nih.gov/health/dci/Diseases/hdw/hdw_causes.html
NHLBI. (November, 2009). What is heart disease? Retrieved from:
http://www.nhlbi.nih.gov/health/dci/Diseases/hdw/hdw_whatis.html
NIH. (n.d.). Heart disease in women. Retrieved from:
http://www.nlm.nih.gov/medlineplus/heartdiseaseinwomen.html
Sutter Health. (2008-2011). Heart attacks in women: can you spot one months ahead? Retrieved
from https://mylifestages.org/featuredarticle/heart/system1_trouble.page
8. Heart disease among women 8
Texas Health Resources. (2011). Women and heart disease. Retrieved from:
http://www.texashealth.org/heartV_template_secondary.cfm?id=4038
WHO. (December, 2010). Deaths from coronary heart disease. The atlas of heart disease and
stroke. Retrieved from:
http://www.who.int/cardiovascular_diseases/en/cvd_atlas_14_deathHD.pdf
WHO. (December, 2010). Prevention: personal choices and actions. The atlas of heart disease
and stroke. Retrieved from:
http://www.who.int/cardiovascular_diseases/en/cvd_atlas_20_personal_choices.pdf
WHO. (November 2009). Women’s health fact sheet. Retrieved from:
http://www.who.int/mediacentre/factsheets/fs334/en/index.html